Activity Preview


Optimizing CRT and New Advances

Activity Type:

  • Course

Release Date: 1/15/2018

Expiration Date: 1/31/2020

  • Participation - no CE credit: 5.75


Cardiac resynchronization therapy (CRT) is more than merely biventricular pacing in patients with ventricular conduction delay and systolic heart failure.  With the introduction of new lead technology and pacing algorithms, prescribing CRT becomes more complex.  Ultimately, the goal is a patient-specific biventricular pacing regimen that optimizes response and clinical care.  This series of CRT lectures is presented by international experts offering their opinions regarding controversial topics in CRT with the intent to provide a review of the literature as well as helpful guidance for specific challenging clinical scenarios.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Resynchronization Therapy Controversies - Permanent Pacing for Severe Conduction Tissue Disease in Patients with Mild LV Dysfunction: To Resynchronize or Not? – duration total <18 minutes
  • Revisiting CRT in mild heart failure: Long-term outcomes mandate a more aggressive approach–duration < 19 minutes
  • Permanent Pacing in a Patient with High Degree AV Block and Preserved Ejection Fraction: Is CRT the Way to Go? – duration <18 minutes
  • Debate - His Bundle Pacing After AVJ Ablation – duration <45 minutes
  • It's Not All About the Lead: Integrating Programming and New Device Technology – duration <98 minutes
    • The Role of LV-Only Pacing in Improving CRT Outcome – duration <25 minutes
    • Rationale and Methods for Achieving AV and VV Optimization – duration <22 minutes
    • Multisite Pacing Do's & Don’ts – duration <27 minutes
    • Optimal Programming for Shock Reduction in CRT Patients – duration <24 minutes
  • Echocardiography Vs Non-invasive Hemodynamic Optimization of AV and VV delay for Cardiac Resynchronization Therapy: The Prospective, multi-centre, randomized, cross-over, non-inferiority BRAVO study.British Randomized Controlled Trial of AV and VV Optimization ("BRAVO") study – duration <20 minutes
  • Impact of Remote Monitoring on Outcome and Survival in CRT Patients – duration <24 minutes
  • Future Directions in CRT: The Impact of Pacing Site on Outcome – duration <20 minutes
  • Infective Complications of CRT in Responder and Superresponder - Periprocedural Management – duration <25 minutes
  • CRT: Emerging Methods and Technology – duration <34 minutes
    • Wireless LV Endocardial Stimulation for Cardiac Resynchronization: Long-term (12 month) Experience of Clinical Efficacy and Clinical Events from Two Centers – duration <16 minutes
    • Leadless LV endocardial stimulation for CRT: Final Outcomes of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study – duration <18 minutes
  • How the Minimally Invasive Surgical Approach Can Get the LV Lead in the Best Location – duration <18 minutes
  • Cardiac Resynchronization Therapy in Patients with Fontan Physiology and Heart Block – duration <13 minutes

*Paticipation only / continuing education credits/points NOT available for this activity


Maurizio Gasparini, MD

Anthony S. Tang, MD, FHRS
London, Ontario

Anne Curtis, MD, FHRS
Buffalo, New York

Kenneth A. Ellenbogen, MD, FHRS
Richmond, Virginia

Jeanne E. Poole, MD, FHRS, CCDS
Seattle, Washington

Marye Gleva, FHRS
St. Louis, Missouri

Christophe Leclercq, MD
Rennes, France

Laurence D. Sterns, MD, FHRS
Victoria, British Columbia,

Zachary I Whinnett, BMBS, PhD
Rickmansworth, United Kingdom

Niraj Varma, MD, PhD
Cleveland, Ohio

Gery Tomassoni, MD, FHRS
Lexington, Kentucky

Bruce L. Wilkoff, MD, FHRS, CCDS
Cleveland, Ohio

Petr Neuzil, MD, PhD
Prague, Czech Republic

Vivek Y. Reddy, MD
New York, New York

Jamil Bashir, MD
Vancouver, British Columbia Canada

Edward O'Leary, MD
Boston, Massachusetts

Access Activity